Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Operating Leases: 2020-2024

Historic Operating Leases for KalVista Pharmaceuticals (KALV) over the last 2 years, with Apr 2024 value amounting to $6.0 million.

  • KalVista Pharmaceuticals' Operating Leases was N/A to $4.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, KalVista Pharmaceuticals' Operating Leases stood at $6.0 million, which was up 469.06% from $1.1 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Operating Leases registered a high of $6.0 million during FY2024, and its lowest value of $1.1 million during FY2020.
  • Over the past 1 years, KalVista Pharmaceuticals' median Operating Leases value was $6.0 million (recorded in 2024), while the average stood at $6.0 million.